Evaluation of the Quality of Guidelines for Myasthenia Gravis with the AGREE II Instrument

Zhang, Zhenchang; Guo, Jia; Su, Gang; Li, Jiong; Hua, Wu; Xie, Xiaodong

doi:10.1371/journal.pone.0111796

Cited by 23 publications

(22 citation statements)

References 33 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Armstrong et al reported similar results (45%) after conducting an evaluation of osteoporosis guidelines focusing on physical activity and safe movement [18]. This domain scored low in several other studies [19, 20, 22, 23], with few exceptions [21]. According to AGREE II, the evaluation of “editorial independence” considers two aspects related to funding bodies or potential authors’ competing interests that may influence the guideline content.…”

Section: Discussionmentioning

confidence: 95%

A critical appraisal of the quality of adult dual-energy X-ray absorptiometry guidelines in osteoporosis using the AGREE II tool: An EuroAIM initiative

et al. 2017

View full text Add to dashboard Cite

ObjectivesDual energy X-ray absorptiometry (DXA) is the most widely used technique to measure bone mineral density (BMD). Appropriate and accurate use of DXA is of great importance, and several guidelines have been developed in the last years. Our aim was to evaluate the quality of published guidelines on DXA for adults.MethodsBetween June and July 2016 we conducted an online search for DXA guidelines, which were evaluated by four independent readers blinded to each other using the AGREE II instrument. A fifth independent reviewer calculated scores per each domain and agreement between reviewers’ scores.ResultsFour out of 59 guidelines met inclusion criteria and were included. They were published between 2005 and 2014. Three out of four guidelines reached a high level of quality, having at least five domain scores higher than 60%. Domain 1 (Scope and Purpose) achieved the highest result (total score = 86.8 ± 3.7%). Domain 6 (Editorial Independence) had the lowest score (total score = 54.7 ± 12.5%). Interobserver agreement ranged from fair (0.230) to good (0.702).ConclusionsOverall, the quality of DXA guidelines is satisfactory when evaluated using the AGREE II instrument. The Editorial Independence domain was the most critical, thus deserving more attention when developing future guidelines.Main messages• Three of four guidelines on DXA had a high quality level (>60%).• Scope/purpose had the highest score (86.8 ± 3.7%).• Editorial Independence had the lowest score (54.7 ± 12.5%).• Interobserver agreement ranged from fair (0.230) to good (0.702).Electronic supplementary materialThe online version of this article (doi:10.1007/s13244-017-0553-6) contains supplementary material, which is available to authorized users.

show abstract

Section: Discussionmentioning

confidence: 95%

A critical appraisal of the quality of adult dual-energy X-ray absorptiometry guidelines in osteoporosis using the AGREE II tool: An EuroAIM initiative

et al. 2017

View full text Add to dashboard Cite

show abstract

“…For instance, the Appraisal of Guidelines Research and Evaluation instrument [21] version II (AGREE II), published in 2009, has been extensively used, validated in several languages, and covers essential information for comprehensive CPG evaluation [19,20]. Several studies worldwide have been conducted for assessing CPG quality using the AGREE II [9–11,16–18,22–25]; however, very little is known regarding CPG quality among low income countries [10]. To date, only one study has evaluated CPG quality in Brazil [18], and none have critically assessed CPGs for NCD treatment quality within a Brazilian sample.…”

Section: Introductionmentioning

confidence: 99%

Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency

et al. 2016

View full text Add to dashboard Cite

BackgroundAnnually, non-communicable diseases (NCDs) kill 38 million people worldwide, with low and middle-income countries accounting for three-quarters of these deaths. High-quality clinical practice guidelines (CPGs) are fundamental to improving NCD management. The present study evaluated the methodological rigor and transparency of Brazilian CPGs that recommend pharmacological treatment for the most prevalent NCDs.MethodsWe conducted a systematic search for CPGs of the following NCDs: asthma, atrial fibrillation, benign prostatic hyperplasia, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease and/or stable angina, dementia, depression, diabetes, gastroesophageal reflux disease, hypercholesterolemia, hypertension, osteoarthritis, and osteoporosis. CPGs comprising pharmacological treatment recommendations were included. No language or year restrictions were applied. CPGs were excluded if they were merely for local use and referred to NCDs not listed above. CPG quality was independently assessed by two reviewers using the Appraisal of Guidelines Research and Evaluation instrument, version II (AGREE II).Main Findings“Scope and purpose” and “clarity and presentation” domains received the highest scores. Sixteen of 26 CPGs were classified as low quality, and none were classified as high overall quality. No CPG was recommended without modification (77% were not recommended at all). After 2009, 2 domain scores (“rigor of development” and “clarity and presentation”) increased (61% and 73%, respectively). However, “rigor of development” was still rated < 30%.ConclusionBrazilian healthcare professionals should be concerned with CPG quality for the treatment of selected NCDs. Features that undermined AGREE II scores included the lack of a multidisciplinary team for the development group, no consideration of patients’ preferences, insufficient information regarding literature searches, lack of selection criteria, formulating recommendations, authors’ conflict of interest disclosures, and funding body influence.

show abstract

“…Moreover, only the author performed the quality assessments, implying a risk of bias. However, the AGREE II instrument has been shown to have adequate levels of validity and reliability , and previous studies indicate high interrater reliability when multiple assessors are used . This, combined with the fact that two separate instruments were used to assess methodological quality, strengthens the findings concerning poor quality.…”

Section: Discussionmentioning

confidence: 92%

Management of physical pain during induced second‐trimester medical abortions: a cross‐sectional study of methodological quality and recommendations in local clinical practice guidelines at Swedish hospitals

Carlsson

2018

Scandinavian Caring Sciences

View full text Add to dashboard Cite

The findings indicate that local clinical practice guidelines about induced second-trimester medical abortions are of inadequate methodological quality and that a large majority lack recommendations concerning systematic pain measurements. Although most recommend prophylactic and as needed pharmacologic management, national inconsistencies exist in Sweden with regard to recommendations of epidural analgesia, nitrous oxide and nonpharmacologic methods. In Sweden, there is room for improvement in the development of these guidelines.

show abstract

Evaluation of the Quality of Guidelines for Myasthenia Gravis with the AGREE II Instrument

Cited by 23 publications

References 33 publications

A critical appraisal of the quality of adult dual-energy X-ray absorptiometry guidelines in osteoporosis using the AGREE II tool: An EuroAIM initiative

A critical appraisal of the quality of adult dual-energy X-ray absorptiometry guidelines in osteoporosis using the AGREE II tool: An EuroAIM initiative

Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency

Management of physical pain during induced second‐trimester medical abortions: a cross‐sectional study of methodological quality and recommendations in local clinical practice guidelines at Swedish hospitals

Contact Info

Product

Resources

About